Recent NAUT News
- Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference • GlobeNewswire Inc. • 02/18/2025 01:00:00 PM
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 • GlobeNewswire Inc. • 02/06/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 10:15:22 PM
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award • GlobeNewswire Inc. • 10/31/2024 12:00:00 PM
- Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference • GlobeNewswire Inc. • 10/30/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2024 08:06:15 PM
- Nautilus Biotechnology Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 • GlobeNewswire Inc. • 10/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:47:37 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:40:38 PM
- Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer • GlobeNewswire Inc. • 09/17/2024 12:00:00 PM
- Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2024 08:10:44 PM
- Nautilus Biotechnology Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/30/2024 12:00:00 PM
- Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:35:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:25:56 PM
- Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 05/23/2024 12:00:00 PM
- Nautilus Biotechnology Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/07/2024 05:15:12 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2024 09:39:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:46:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:42:01 PM
North Bay Resources Announces Production of 8.5 Ounces Per Ton Gold Concentrate, Bishop Gold Mill, California • NBRI • Feb 19, 2025 8:59 AM
YCRM ReachOut Technology Returns to Trading: CEO Rick Jordan Lays Out Blockchain CyberSecurity Strategy and Industry-First AI MSP Partnership In Shareholder Letter • YCRM • Feb 18, 2025 11:20 AM
VAYK Confirms No Dilution Following Recent Acquisition and 11 Million Insider Purchase • VAYK • Feb 18, 2025 9:30 AM
UAV Corp. (OTC: UMAV) Announces Nationwide Teleconference to Provide Shareholders with Key Updates on Contracts, Future Plans, and Share Structure • UMAV • Feb 18, 2025 8:30 AM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM